- Review
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
- Mateusz Kciuk,
- Adrianna Gielecińska,
- Somdutt Mujwar,
- Damian Kołat,
- Żaneta Kałuzińska-Kołat,
- Ismail Celik and
- Renata Kontek
Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens currently in clinical use. However, the precise mechanisms of DOX’s action are not fully understood. Emerging evidence points to the pleiotropic anticancer ac...

